title: Use of insulin glargine during the first weeks of pregnancy in five type 1 diabetic women.
authors.forename: Graziano
authors.initials: G
authors.lastname: Di Cianni
authors.forename: Laura
authors.initials: L
authors.lastname: Volpe
authors.forename: Cristina
authors.initials: C
authors.lastname: Lencioni
authors.forename: Kyriazoula
authors.initials: K
authors.lastname: Chatzianagnostou
authors.forename: Ilaria
authors.initials: I
authors.lastname: Cuccuru
authors.forename: Alessandra
authors.initials: A
authors.lastname: Ghio
authors.forename: Luca
authors.initials: L
authors.lastname: Benzi
authors.forename: Stefano
authors.initials: S
authors.lastname: Del Prato
mesh_terms: D000328:Adult; D001835:Body Weight; D036861:Delivery, Obstetric; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007231:Infant, Newborn; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting